1
Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma
Condition(s):AsthmaLast Updated:July 17, 2014Terminated
Fenoterol as an Intervention: 27 Clinical Trials
Hide Studies Not Open or Pending
2
Initial Study of Fenoterol as a Treatment for Heart Failure
Condition(s):Congestive Heart FailureLast Updated:July 3, 2018Completed
3
Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction
Condition(s):Acute Bronchial Obstruction, AsthmaLast Updated:March 23, 2011Completed
4
A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients
Condition(s):AsthmaLast Updated:January 15, 2013Completed
5
Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 18, 2014Completed
6
Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:October 31, 2013Completed
7
Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients
Condition(s):AsthmaLast Updated:July 11, 2014Completed
8
Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:July 11, 2014Completed
9
Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma
Condition(s):AsthmaLast Updated:July 11, 2014Completed
10
Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition
Condition(s):Pulmonary Disease, Chronic Obstructive; AsthmaLast Updated:July 11, 2014Completed
11
Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:July 11, 2014Terminated
12
Aerosol Therapy in Obese COPD Patients.
Condition(s):Chronic Obstructive Pulmonary Disease Moderate; ObesityLast Updated:May 4, 2018Active, not recruiting
13
Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:September 9, 2013Unknown status
14
Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 4, 2014Completed
15
Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 1, 2014Completed
16
Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 1, 2014Completed
17
Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 2, 2014Completed
18
Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 2, 2014Completed
19
Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:July 11, 2014Terminated
20
Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.
Condition(s):Pulmonary Disease, Chronic Obstructive; AsthmaLast Updated:December 27, 2017Completed
21
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition(s):Pulmonary Disease, Chronic Obstructive; AsthmaLast Updated:October 28, 2013Completed
22
Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1
Condition(s):Drug Metabolism; Membrane TransportLast Updated:May 11, 2016Completed
23
Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 2, 2014Completed
24
Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 2, 2014Completed
25
Different Positive Pressure Strategies in COPD Patients.
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:July 30, 2018Active, not recruiting
26
Heliox and Posture in Patients With Asthma
Condition(s):Acute AsthmaLast Updated:June 16, 2009Completed
27
Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:October 27, 2016Unknown status